gilbenclamide
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 25, 2018 (NCT03741530)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04859452 | Phase 1 | May 26, 2021 | Shijiazhuang Pharma Group (CSPC) |
| NCT03741530 | N/A | Nov 25, 2018 | Xijing Hospital |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shijiazhuang Pharma Group (CSPC) | For profit | 1 | 1 | 1 | 2021 |
| Xijing Hospital | Academic/Hospital | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1